External Source

Interim Analysis Of The Elm-2 Study: Odronextamab In Patients With R/r Follicular Lymphoma

2024 2:43
Synopsis
Jose Villasboas, MD, Mayo Clinic, Rochester, MN, discusses the results of a pre-specified interim analysis of the Phase II ELM-2 ...
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.